Metformin Sandoz

Metformin Hydrochloride, the active ingredient in Metformin Sandoz, is a biguanide presented as an oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus and related insulin‑resistance conditions. GNH USA supplies Metformin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Sandoz, a biguanide antidiabetic, is used to improve glycemic control in type 2 diabetes mellitus and related disorders.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. Gestational diabetes mellitus: helps achieve target glucose when diet alone is insufficient. Polycystic ovary syndrome: improves insulin sensitivity and may regularise menstrual cycles.

Metformin Sandoz is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often transient. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Vitamin B12 deficiency: may develop with long‑term use. - Hypoglycaemia (when combined with other glucose‑lowering agents). - Pancreatitis: inflammation of the pancreas.

When prescribing Metformin Sandoz, clinicians should consider several safety measures.

Renal function assessment: evaluate creatinine clearance before initiation and periodically. Monitor blood glucose: adjust therapy based on glycaemic response. Liver function evaluation: avoid use in severe hepatic impairment. Vitamin B12 monitoring: check levels during long‑term therapy. Avoid in severe renal or hepatic failure: contraindicated in these conditions. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Sandoz may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Iodinated contrast agents: risk of acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis. - Diuretics that reduce renal perfusion: may impair metformin excretion. - Nitrates: concurrent use may increase risk of hypotension.

Moderate Interactions (Monitor Closely): - Sulfonylureas: heightened risk of hypoglycaemia. - Beta‑blockers: may mask hypoglycaemic symptoms. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Warfarin: possible alteration of INR, require monitoring. - Thyroid hormones: may affect metabolic rate and glucose control.